The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor–null mice
Open accessAbstract
ADP is a key agonist in hemostasis and thrombosis. ADP-induced platelet activation involves the purinergic P2Y(1) receptor, which is responsible for shape change through intracellular calcium mobilization. This process also depends on an unidentified P2 receptor (P2cyc) that leads to adenylyl cyclase inhibition and promotes the completion and amplification of the platelet response. P2Y(1)-null mice were generated to define the role of the P2Y(1) receptor and to determine whether the unidentified P2cyc receptor is distinct from P2Y(1). These mice are viable with no apparent abnormalities affecting their development, survival, reproduction, or the morphology of their platelets, and the platelet count in these animals is identical to that of wild-type mice. However, platelets from P2Y(1)-deficient mice are unable to aggregate in response to usual concentrations of ADP and display impaired aggregation to other agonists, while high concentrations of ADP induce platelet aggregation without shape change. In addition, ADP-induced inhibition of adenylyl cyclase still occurs, demonstrating the existence of an ADP receptor distinct from P2Y(1). P2Y(1)-null mice have no spontaneous bleeding tendency but are resistant to thromboembolism induced by intravenous injection of ADP or collagen and adrenaline. Hence, the P2Y(1) receptor plays an essential role in thrombotic states and represents a potential target for antithrombotic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
BORN, G. V. R. (1962) · Nature · doi:10.1038/194927b0 · Cited by 4,294
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
Savage, B., Almus-Jacobs, F., & Ruggeri, Z. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81607-4 · Cited by 801
Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood Platelets
GAARDER, A., JONSEN, J., LALAND, S., HELLEM, A., & OWREN, P. A. (1961) · Nature · doi:10.1038/192531a0 · Cited by 786
Lufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationEnjyoji, K., Sévigny, J., Lin, Y., Frenette, P. S., Christie, P. D., Esch, J. S. A., Imai, M., Edelberg, J. M., Rayburn, H., Lech, M., et al. (1999) · Nature Medicine · doi:10.1038/12447 · Cited by 565
Cloning and functional expression of a brain G‐protein‐coupled ATP receptor
Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F., Burnstock, G., & Barnard, E. A. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81397-i · Cited by 548
Jin, J., & Kunapuli, S. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8070 · Cited by 540
Molecular Basis for ADP-induced Platelet Activation
Jin, J., Daniel, J. L., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2030 · Cited by 477
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Identification of the platelet ADP receptor targeted by antithrombotic drugs
Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.-B., Nurden, P., Nurden, A., Julius, D., et al. (2001) · Nature · doi:10.1038/35051599 · Cited by 1,423
Abbracchio, M. P., Burnstock, G., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.3 · Cited by 1,281
Self-citationMammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
Purine and pyrimidine receptors
Burnstock, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6497-0 · Cited by 929
A shear gradient–dependent platelet aggregation mechanism drives thrombus formation
Nesbitt, W. S., Westein, E., Tovar-Lopez, F. J., Tolouei, E., Mitchell, A., Fu, J., Carberry, J., Fouras, A., & Jackson, S. P. (2009) · Nature Medicine · doi:10.1038/nm.1955 · Cited by 862
Activation of Platelet Function Through G Protein–Coupled Receptors
Offermanns, S. (2006) · Circulation Research · doi:10.1161/01.res.0000251742.71301.16 · Cited by 725
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes
von Kügelgen, I. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.014 · Cited by 541
Platelets at work in primary hemostasis
Broos, K., Feys, H. B., De Meyer, S. F., Vanhoorelbeke, K., & Deckmyn, H. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.03.002 · Cited by 502
Molecular pharmacology of P2Y-receptors
von Kügelgen, I., & Wetter, A. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000310 · Cited by 481
Platelet physiology and thrombosis
Andrews, R. K., & Berndt, M. C. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.07.020 · Cited by 445
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
Angelillo-Scherrer, A., de Frutos, P. G., Aparicio, C., Melis, E., Savi, P., Lupu, F., Arnout, J., Dewerchin, M., Hoylaerts, M. F., Herbert, J.-M., et al. (2001) · Nature Medicine · doi:10.1038/84667 · Cited by 441
ADP Receptors of Platelets and their Inhibition
Gachet, C. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616220 · Cited by 415
Self-citationFoster, C. J., Prosser, D. M., Agans, J. M., Zhai, Y., Smith, M. D., Lachowicz, J. E., Zhang, F. L., Gustafson, E., Monsma, F. J., Wiekowski, M. T., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12242 · Cited by 415
Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance
Cattaneo, M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145980.39477.a9 · Cited by 411
Scientific and therapeutic advances in antiplatelet therapy
Bhatt, D. L., & Topol, E. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd985 · Cited by 407
Purine and Pyrimidine (P2) Receptors as Drug Targets
Jacobson, K. A., Jarvis, M. F., & Williams, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020046y · Cited by 352
P2 receptors in cardiovascular regulation and disease
Erlinge, D., & Burnstock, G. (2008) · Purinergic Signalling · doi:10.1007/s11302-007-9078-7 · Cited by 344
Mutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
P2 receptors, platelet function and pharmacological implications
Gachet, C. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-11-0673 · Cited by 297
Self-citationREGULATION OF PLATELET FUNCTIONS BY P2 RECEPTORS
Gachet, C. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141207 · Cited by 295
Self-citationP2 Purinergic Receptors: Modulation of Cell Function and Therapeutic Potential
Burnstock, G., & Williams, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38983-9 · Cited by 275
Angelillo-Scherrer, A., Burnier, L., Flores, N., Savi, P., DeMol, M., Schaeffer, P., Herbert, J.-M., Lemke, G., Goff, S. P., Matsushima, G. K., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22079 · Cited by 266
Metadata
- Authors
- Léon, C., Hechler, B., Freund, M., Eckly, A., Vial, C., Ohlmann, P., Dierich, A., LeMeur, M., Cazenave, J.-P., & Gachet, C.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-12-15
- Volume
- 104
- Issue
- 12
- Pages
- 1731-1737
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2134723230
- Cited by
- 460
- References
- 31
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.